French pharmaceutical giant Sanofi on Friday said the European Medicines Agency had conditionally approved its anti-cancer drug Libtayo, the first drug of its kind to be authorised for use in the EU.
from Latest News http://bit.ly/2GNumm5
In first for EU, anti-skin cancer drug approved
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment